Not applicableStudy completedNCT03746782What this trial is testingApixaban + DAPT in Lowering Platelet Reactivity and Thrombin GenerationWho this might be right forAcute Coronary Syndrome CirQuest Labs, LLC 40
Testing effectiveness (Phase 2)Study completedNCT01585259What this trial is testingAnfibatide Phase Ib-IIa Clinical TrialWho this might be right forNon-ST Segment Elevation Myocardial Infarction Lee's Pharmaceutical Limited 90
Not applicableStudy completedNCT01358422What this trial is testingOccurrence of Bleeding and Thrombosis During Antiplatelet Therapy in Non-cardiac SurgeryWho this might be right forBleedingThrombosisCardiac Events European Society of Anaesthesiology 830
Post-approval studies (Phase 4)UnknownNCT04090281What this trial is testingImplementing Precision Medicine Approaches to Guide Anti-platelet SelectionWho this might be right forAcute Coronary Syndrome (ACS)STEMI - ST Elevation Myocardial Infarction (MI)NSTEMI - Non-ST Segment Elevation MI+1 more University of Southern California 200
Post-approval studies (Phase 4)Study completedNCT04624854What this trial is testingDual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)Who this might be right forCoronary Artery DiseaseMyocardial IschemiaAcute Coronary Syndrome+7 more Harbin Medical University 8,250
Post-approval studies (Phase 4)UnknownNCT00954707What this trial is testingCYPRESS - CYPHER for Evaluating Sustained SafetyWho this might be right forCoronary Artery Disease Cordis US Corp. 2,509
Post-approval studies (Phase 4)UnknownNCT01267734What this trial is testingHarmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - SAfety & EffectiveneSS of Drug-ElUting Stents & Anti-platelet REgimenWho this might be right forCoronary Heart Disease Seoul National University Hospital 3,750
Post-approval studies (Phase 4)Ended earlyNCT01346865What this trial is testingDrug-Eluting Stenting Followed by Cilostazol tREAtment Reduces SErious Adverse Cardiac Events (DECREASE-PCI)Who this might be right forCoronary Artery Disease Seung-Jung Park 402
Post-approval studies (Phase 4)Study completedNCT02330640What this trial is testingA Single-center, Prospective,Randomized Study of Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Dual Anti-platelet Therapy After Coronary Artery Bypass GraftingWho this might be right forAntiplatelet Therapy of Coronary Artery Bypass Chinese Academy of Medical Sciences, Fuwai Hospital 137
Not applicableStudy completedNCT03848572What this trial is testingRepetitive Assessement of PRECISE-DAPT ScoreWho this might be right forCardiovascular DiseasesInterventional Cardiology University of Roma La Sapienza 500
Not applicableStudy completedNCT00998127What this trial is testingPatterns of Non-Adherence to Dual Anti-Platelet Regimen In Stented PatientsWho this might be right forMedication Non-adherenceStent Thrombosis Icahn School of Medicine at Mount Sinai 5,031
Early research (Phase 1)Ended earlyNCT01561950What this trial is testingEfficacy of Activated Recombinant Human Factor VII in Healthy Volunteers Treated for Punch Biopsy Mediated BleedingWho this might be right forHaemostasisHealthy Novo Nordisk A/S 91
Not applicableStudy completedNCT03526614What this trial is testingREpetitive Assessement of SCOREs in Patients on Dual Antiplatelet TherapyWho this might be right forDual Anti-platelet Therapy University of Roma La Sapienza 480
Not applicableStudy completedNCT04999293What this trial is testingTicagrelor in Elderly Patients Undergoing Percutaneous Coronary InterventionWho this might be right forPlatelet Aggregation InhibitorsDual Anti-Platelet TherapyAged+1 more The First Affiliated Hospital of Dalian Medical University 1,505
Not applicableStudy completedNCT03601013What this trial is testingDemographical and Clinical Profile of Patients on Dual Antıplatelet Therapy and Mean Precise-DAPT and DAPT Scores in TurkeyWho this might be right forAnti-platelet Therapy Cardiovascular Academy Society, Turkey 963
Post-approval studies (Phase 4)Study completedNCT02118870What this trial is testingShort-term Dual Anti Platelet Therapy in Patients With ACS Treated With the COMBO Dual-therapy StentWho this might be right forAcute Coronary Syndrome Diagram B.V. 1,500
Not applicableEnded earlyNCT04885816What this trial is testingDrug-eluting Balloon Versus Drug-eluting Stent for High Bleeding Risk AngioplastyWho this might be right forHigh Bleeding RiskCoronary Artery Disease (CAD)Percutaneous Coronary Intervention (PCI) Instituto Nacional de Cardiologia Ignacio Chavez 5
Post-approval studies (Phase 4)Active Not RecruitingNCT03947229What this trial is testingComparison of CLOpidogrel Monotherapy Versus Extended Dual-antiplatelet Therapy Beyond 12 Months After Implantation of Drug-eluting StEnts in High-risk Lesions or Patients; A-CLOSE TrialWho this might be right forCoronary Artery DiseaseDES Yonsei University 3,200
Large-scale testing (Phase 3)Looking for participantsNCT07512960What this trial is testingDuration of Dual Anti-Platelet Therapy in Chronic Limb Threatening Ischemia After Distal RevascularizationWho this might be right forCLTI Defined as Rutherford Category 4 or 5 Fondation Hôpital Saint-Joseph 614
Testing effectiveness (Phase 2)Study completedNCT05567562What this trial is testingAnti-Platelets in Chronic Obstructive Pulmonary DiseaseWho this might be right forCOPDEmphysemaEmphysema or COPD Brigham and Women's Hospital 15